Photo from wikipedia
Rituximab is an anti‐CD 20 agent used widely in renal transplant recipients. Its use is associated with various infections; however, its association with tuberculosis (TB) is not well established and… Click to show full abstract
Rituximab is an anti‐CD 20 agent used widely in renal transplant recipients. Its use is associated with various infections; however, its association with tuberculosis (TB) is not well established and has not been studied in post renal transplantation patients.
Keywords:
rituximab;
risk tuberculosis;
renal transplant;
transplant recipients
Journal Title: Transplant Infectious Disease
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Transplant Infectious Disease
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!